Ticker Details
Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.
IPO Date:	September 11, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$298.5M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.18 | 2.49%
Avg Daily Range (30 D):	$0.14 | 1.78%
Avg Daily Range (90 D):	$0.17 | 2.16%

Institutional Daily Volume
Avg Daily Volume:	.09M
Avg Daily Volume (30 D):	.1M
Avg Daily Volume (90 D):	.12M

Trade Size
Avg Trade Size (Sh.):	129
Avg Trade Size (Sh.) (30 D):	71
Avg Trade Size (Sh.) (90 D):	96

Institutional Trades
Total Institutional Trades:	41
Avg Institutional Trade:	$2.78M
Avg Institutional Trade (30 D):	$.81M
Avg Institutional Trade (90 D):	$2.51M
Avg Institutional Trade Volume:	.35M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$5.82M
Avg Closing Trade (30 D):	$1.22M
Avg Closing Trade (90 D):	$1.22M
Avg Closing Volume:	709.79K

News

Dec 26, 2025 @ 10:44 PM Southpoint holdings in Fennec Pharmaceuticals Inc.... Source: Na

Nov 14, 2025 @ 4:11 AM Fennec Pharmaceuticals Announces Private Offering ... Source: Fennec Pharmaceuticals Inc.

Nov 14, 2025 @ 4:07 AM Fennec Pharmaceuticals Announces Pricing of Offeri... Source: Fennec Pharmaceuticals Inc.

Aug 14, 2025 @ 3:04 PM Fennec Q2 Sales Jump 33 Percent Source: Na

Jun 3, 2025 @ 8:31 PM Fennec Announces Results of Annual Meeting Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.26	$-.02	$-.11
Diluted EPS	$-.26	$-.02	$-.11
Revenue	$38.79M	$12.46M	$9.65M
Gross Profit
Net Income / Loss	$-6.94M	$-.64M	$-3.15M
Operating Income / Loss	$-4.66M	$-.19M	$-2.73M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Sep 05, 2014	1:3
Aug 30, 2011	1:18
Aug 02, 2005	1:5